HT
AUPH icon

HAP Trading’s Aurinia Pharmaceuticals AUPH Stock Holding History

HAP Trading’s Portfolio AUPH Stock Details AUPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-14,800
Closed -$6K – 2215
2021
Q4 		$6K Sell
14,800
-12,700
-46% -$301K ﹤0.01% 2169
2021
Q3 		$19K Buy
27,500
+1,400
+5% +$22.2K ﹤0.01% 1818
2021
Q2 		$60K Buy
+26,100
New +$332K ﹤0.01% 1405
2021
Q1 		– Sell
-213,800
Closed -$546K – 1921
2020
Q4 		$546K Buy
213,800
+9,800
+5% +$143K 0.02% 589
2020
Q3 		$705K Buy
+204,000
New +$2.96M 0.03% 330
2020
Q2 		– Sell
-258,200
Closed -$919K – 1679
2020
Q1 		$919K Buy
+258,200
New +$4.55M 0.06% 232
2017
Q2 		– Sell
-143,700
Closed -$10K – 939
2017
Q1 		$10K Buy
143,700
+8,200
+6% +$37.9K ﹤0.01% 911
2016
Q4 		$106K Buy
+135,500
New +$436K 0.01% 556

Other funds holding AUPH

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

HAP Trading's AUPH Position: Q1 2021 in Review

HAP Trading sold out of Aurinia Pharmaceuticals (AUPH) in Q1 2021, closing a stake of 63,456 shares — an estimated $921K sold.

HAP Trading first reported a position in AUPH in Q4 2019 and held it in 4 quarters. The position peaked at $960K in Q3 2020. 170 funds tracked by Wall St. Rank hold AUPH as of Q1 2021.

  • HAP Trading reported no remaining Aurinia Pharmaceuticals position as of Q1 2021 after selling out during the quarter.
  • HAP Trading sold 63,456 Aurinia Pharmaceuticals shares in Q1 2021, an estimated $921K.
  • HAP Trading first reported a position in Aurinia Pharmaceuticals in Q4 2019 and held it in 4 quarters.
  • HAP Trading's Aurinia Pharmaceuticals position peaked at $960K in Q3 2020.
  • 170 funds tracked by Wall St. Rank held Aurinia Pharmaceuticals as of Q1 2021.

Based on HAP Trading's 13F filing for Q1 2021, filed 14 May 2021.